PASP

Clinical trials for PASP explained in plain language.

Never miss a new study

Get alerted when new PASP trials appear

Sign up with your email to follow new studies for PASP, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Heart failure drug probed for hidden benefit on lung pressure

Disease control Completed

Researchers are studying whether sacubitril-valsartan, a standard heart failure drug, can lower estimated pulmonary artery systolic pressure in people with reduced ejection fraction heart failure. The trial enrolls adults with an ejection fraction of 40% or less. Participants rec…

Matched conditions: PASP

Phase 1 • Sponsor: Aswan University • Aim: Disease control

Last updated Sep 13, 2026 00:00 UTC

PASP

Get alerted when new PASP trials appear

Heart failure drug probed for hidden benefit on lung pressure